| A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB) (NCT04138875) | Yale University | 2022-01-01 |
| Positive Psychology Intervention In HSCT (NCT05147311) | Brigham and Women's Hospital | 2021-11-17 |
| First-in-Human Study of ICT01 in Patients With Advanced Cancer (NCT04243499) | ImCheck Therapeutics, an Ipsen company | 2020-03-05 |
| Feasibility Study of a Diary for Allogenic Hematopoietic Stem Cell Transplantation Patients and Families (NCT04172818) | Centre Hospitalier Universitaire, Amiens | 2019-11-01 |
| Hematopoietic Stem Cell Transplantation and Childhood Leukemia Quality of Life in SIbling DONors (NCT03659071) | Assistance Publique Hopitaux De Marseille | 2018-12-01 |
| A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients (NCT03654404) | Brigham and Women's Hospital | 2018-09-11 |
| Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22 (NCT03185494) | Chinese PLA General Hospital | 2017-08-01 |
| Ibrutinib, Nivolumab and Blinatumomab in Richter Transformation (NCT03121534) | M.D. Anderson Cancer Center | 2017-06-22 |
| Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20 (NCT03097770) | Chinese PLA General Hospital | 2017-04-01 |
| Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma (NCT03110640) | First Affiliated Hospital of Wenzhou Medical University | 2016-10-01 |
| Combination Transfer of αCD19-TCRz-41BB and αCD22-TCRz-41BB CAR-T Cells for B-cell Hematologic Malignancy (NCT02903810) | Xuzhou Medical University | 2016-09-01 |
| Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/Lymphoma (NCT02685670) | The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine | 2016-02-01 |
| Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases (NCT02248597) | Wake Forest University Health Sciences | 2015-02-25 |
| Lymphocyte Profiles and Activation Status in Patients With Graft-Versus-Host Disease (NCT01988701) | Ohio State University Comprehensive Cancer Center | 2015-02-01 |
| Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy (NCT02116530) | Alliance for Clinical Trials in Oncology | 2014-08-20 |
| CART-19 Immunotherapy in Mantle Cell Lymphoma (NCT02081937) | Chinese PLA General Hospital | 2014-03-01 |
| Improved Outcome in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients by Reducing Caregiver Distress (NCT02037568) | University of Colorado, Denver | 2014-01-01 |
| Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor (NCT01982682) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2013-11-04 |
| Quality of Life in Caregivers of Hospitalized Older Patients With Cancer (NCT01866969) | City of Hope Medical Center | 2013-06-01 |
| Brentuximab Vedotin After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01620229) | Fred Hutchinson Cancer Center | 2013-06-01 |
| Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant (NCT01758484) | Fred Hutchinson Cancer Center | 2013-04-01 |
| Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy (NCT01735604) | Chinese PLA General Hospital | 2013-01-01 |
| Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant (NCT01660347) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-08-01 |
| Effects of Healing Touch on Patients Undergoing Hematopoietic Stem Cell Transplant (NCT02194413) | University of Iowa | 2012-03-01 |
| Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant (NCT01199562) | City of Hope Medical Center | 2010-12-01 |
| Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) (NCT01212380) | Ohio State University Comprehensive Cancer Center | 2010-10-01 |
| CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy (NCT01029366) | University of Pennsylvania | 2010-03-17 |
| Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease (NCT00959231) | Cancer Research UK | 2009-01-01 |
| Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT) (NCT00833898) | University of Colorado, Denver | 2008-11-01 |
| Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers (NCT00896792) | Mayo Clinic | 2008-10-10 |
| Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain (NCT00737191) | Mayo Clinic | 2008-08-01 |
| Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy (NCT00670917) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2008-05-07 |
| Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer (NCT00769951) | Case Comprehensive Cancer Center | 2008-02-01 |
| Screening to Predict Weight Loss in Patients With Cancer (NCT00710632) | Queen's Medical Center | 2007-09-01 |
| Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00489203) | Fred Hutchinson Cancer Center | 2007-04-01 |
| Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer (NCT00899808) | Rutgers, The State University of New Jersey | 2006-05-01 |
| Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies (NCT01056614) | Fred Hutchinson Cancer Center | 2004-09-01 |
| Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas (NCT00089089) | National Cancer Institute (NCI) | 2004-09-01 |
| Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies (NCT00070239) | National Cancer Institute (NCI) | 2003-08-01 |
| Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00068315) | National Cancer Institute (NCI) | 2003-07-01 |
| Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer (NCT00049504) | Fred Hutchinson Cancer Center | 2002-01-01 |
| Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts. (NCT02158767) | Leland Metheny | |